Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 33 (3), 238-46

Comparing Hospice and Nonhospice Patient Survival Among Patients Who Die Within a Three-Year Window


Comparing Hospice and Nonhospice Patient Survival Among Patients Who Die Within a Three-Year Window

Stephen R Connor et al. J Pain Symptom Manage.


There is a widespread belief by some health care providers and the wider community that medications used to alleviate symptoms may hasten death in hospice patients. Conversely, there is a clinical impression among hospice providers that hospice might extend some patients' lives. We studied the difference of survival periods of terminally ill patients between those using hospices and not using hospices. We performed retrospective statistical analysis on selected cohorts from large paid claim databases of Medicare beneficiaries for five types of cancer and congestive heart failure (CHF) patients. We analyzed the survival of 4493 patients from a sample of 5% of the entire Medicare beneficiary population for 1998-2002 associated with six narrowly defined indicative markers. For the six patient populations combined, the mean survival was 29 days longer for hospice patients than for nonhospice patients. The mean survival period was also significantly longer for the hospice patients with CHF, lung cancer, pancreatic cancer, and marginally significant for colon cancer (P=0.08). Mean survival was not significantly different (statistically) for hospice vs. nonhospice patients with breast or prostate cancer. Across groups studied, hospice enrollment is not significantly associated with shorter survival, but for certain terminally ill patients, hospice is associated with longer survival times. The claims-based method used death within three years as a surrogate for a clinical judgment to recommend hospice, which means our findings apply to cases where a clinician is very sure the patient will die within three years, and it points to the need to validate these findings.

Similar articles

  • Medicare Cost in Matched Hospice and Non-Hospice Cohorts
    B Pyenson et al. J Pain Symptom Manage 28 (3), 200-10. PMID 15336332.
    Hospice care is perceived as enhancing life quality for patients with advanced, incurable illness, but cost comparisons to non-hospice patients are difficult to make. The …
  • Survival of Medicare Patients After Enrollment in Hospice Programs
    NA Christakis et al. N Engl J Med 335 (3), 172-8. PMID 8657216.
    Most patients who enter hospice care do so late in the course of their terminal illnesses. The timing of enrollment in hospice programs varies substantially with the char …
  • Variations in Hospice Use Among Cancer Patients
    NL Keating et al. J Natl Cancer Inst 98 (15), 1053-9. PMID 16882942.
    Health care within a large integrated delivery system has the potential to eliminate racial and ethnic disparities in hospice use, but substantial variation in hospice us …
  • When Hospice Is the Best Option: An Opportunity to Redefine Goals
    M Prince-Paul. Oncology (Williston Park) 23 (4 Suppl Nurse Ed), 13-7. PMID 19856592. - Review
    More than 50% of patients diagnosed with cancer in 2008 died in the same year, according to estimates from the American Cancer Society. Clearly, while survival rates for …
  • Integrating Palliative Care Into Heart Failure Care
    PJ Hauptman et al. Arch Intern Med 165 (4), 374-8. PMID 15738365. - Review
    Heart failure is a condition for which both palliative care and hospice care can be appropriate. The disease's increasing prevalence and predilection for elderly patients …
See all similar articles

Cited by 93 PubMed Central articles

See all "Cited by" articles

Publication types

LinkOut - more resources